Download PDF
Int J Angiol 2023; 32(03): 172-178
DOI: 10.1055/s-0042-1758384
Original Article

Impact of Ultrasound-Guided Foam Sclerotherapy for Pain Control in Patients with Chronic Venous Disease and Great Saphenous Vein Reflux

Douglas Poschinger-Figueiredo 
1   Teaching and Health Care Unit of Vascular and Endovascular Surgery (CT Vascular), Pedro Ernesto University Hospital (HUPE), Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil
,
Carlos Eduardo Virgini-Magalhães 
1   Teaching and Health Care Unit of Vascular and Endovascular Surgery (CT Vascular), Pedro Ernesto University Hospital (HUPE), Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil
,
Claudia Salvador Amorim
1   Teaching and Health Care Unit of Vascular and Endovascular Surgery (CT Vascular), Pedro Ernesto University Hospital (HUPE), Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil
,
Alessandra Krykhtine Peres Poschinger 
1   Teaching and Health Care Unit of Vascular and Endovascular Surgery (CT Vascular), Pedro Ernesto University Hospital (HUPE), Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil
,
Fernanda Pires Chequer
1   Teaching and Health Care Unit of Vascular and Endovascular Surgery (CT Vascular), Pedro Ernesto University Hospital (HUPE), Rio de Janeiro State University (UERJ), Rio de Janeiro, Brazil
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Chronic venous disease (CVD) associated with great saphenous vein (GSV) reflux has a higher prevalence of pain in the lower limbs. This study evaluates the impact of ultrasound-guided foam sclerotherapy (UGFS) for GSV and symptom control, accessed by the visual analogue scale (VAS). Patients with CVD who underwent GSV-UGFS were included in this retrospective cohort (417 limbs). The pain was measured before and after the treatment. The scale alteration was assessed as a function of age, sex, Clinical Etiologic Anatomic Pathophysiologic (CEAP) classes, total of sclerotherapy sessions, GSV occlusion patterns, and ulcer healing. Majority of patients were female (59.2%), and the mean age was 56 ± 11.5 years. In the total sample, 78.2% of the GSVs were fully occluded, 19.7% had partial occlusion, 2.2% remained open, and 3.2 ± 1.9 (median = 3.0) sessions were performed. The reduction of symptoms occurred in 88.3% of participants (VAS drop median = 4.8). Patients younger than 50 years and females had the greatest VAS decreases. When comparing the outcomes of complete occlusion versus partial occlusion, there was no significant difference in VAS pain reduction (p = 0.14). The comparison between CEAP clinical classes also did not show statistically significant differences in delta VAS (p = 0.71). GSV-UGFS was effective for pain control. However, this improvement does not appear to be related to the pattern of occlusion, indicating that in the short term, the outcomes of total and partial occlusion suggest successful management of symptoms. Other aspects such as gender, age, pretreatment pain intensity, and CEAP classes seem to play a role in the clinical outcome.

Keywords

sclerotherapy - saphenous vein - venous insufficiency - chronic venous disease polidocanol - vascular surgery ambulatory - ulcer

Note

This study was accepted for oral abstract presentation at XIX World Congress of Phlebology – 2022 (UIP) Istanbul, Turkey.




Publication History

Article published online:
11 November 2022

© 2022. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F. VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012; 31 (02) 105-115
    Google Scholar
  • 2 Danziger N. [Pathophysiology of pain in venous disease]. J Mal Vasc 2007; 32 (01) 1-7
    PubMedGoogle Scholar
  • 3 Venermo M, Saarinen J, Eskelinen E. et al; Finnish Venous Study Collaborators. Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of great saphenous varicose veins. Br J Surg 2016; 103 (11) 1438-1444
    CrossrefPubMedGoogle Scholar
  • 4 Poschinger-Figueiredo D, Virgini-Magalhães CE, Porto LC. et al. Radiofrequency ablation for axial reflux associated with foam sclerotherapy for varicosities in one-step approach: a prospective cohort study comprising large diameters saphenous veins. Vasc Health Risk Manag 2021; 17 (July): 379-387
    CrossrefPubMedGoogle Scholar
  • 5 De Cassai A, Boscolo A, Tonetti T, Ban I, Ori C. Assignment of ASA-physical status relates to anesthesiologists' experience: a survey-based national-study. Korean J Anesthesiol 2019; 72 (01) 53-59
    CrossrefPubMedGoogle Scholar
  • 6 Eklöf B, Rutherford RB, Bergan JJ. et al. Revision of the CEAP classification for chronic venous disorders: a consensus statement. Vasa 2005; 34 (03) 157-161
    CrossrefPubMedGoogle Scholar
  • 7 Rabe E, Breu FX, Cavezzi A. et al; Guideline Group. European guidelines for sclerotherapy in chronic venous disorders. Phlebology 2014; 29 (06) 338-354
    CrossrefPubMedGoogle Scholar
  • 8 Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001; 27 (01) 58-60
    PubMedGoogle Scholar
  • 9 Rai A, Porsalman M, Khatony A, Sobhiyeh M. Comparison of foam sclerotherapy versus radiofrequency ablation in the treatment of primary varicose veins due to incompetent great saphenous vein: randomized clinical trial. J Vasc Nurs 2019; 37 (04) 226-231
    CrossrefPubMedGoogle Scholar
  • 10 Cavezzi A, Mosti G, Campana F, Tessari L, Bastiani L, Urso SU. Catheter foam sclerotherapy of the great saphenous vein, with perisaphenous tumescence infiltration and saphenous irrigation. Eur J Vasc Endovasc Surg 2017; 54 (05) 629-635
    CrossrefPubMedGoogle Scholar
  • 11 Gloviczki P, Comerota AJ, Dalsing MC. et al; Society for Vascular Surgery, American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53 (5, Suppl): 2S-48S
    CrossrefPubMedGoogle Scholar
  • 12 van Eekeren RRJP, Boersma D, Konijn V, de Vries JPPM, Reijnen MMJP. Postoperative pain and early quality of life after radiofrequency ablation and mechanochemical endovenous ablation of incompetent great saphenous veins. J Vasc Surg 2013; 57 (02) 445-450
    CrossrefPubMedGoogle Scholar
  • 13 Nesbitt C, Bedenis R, Bhattacharya V, Stansby G. Endovenous ablation (radiofrequency and laser) and foam sclerotherapy versus open surgery for great saphenous vein varices. Cochrane Database Syst Rev 2014; 2014 (07) CD005624
    PubMedGoogle Scholar
  • 14 Neto FC, Gomes de Oliveira R, Thomazinho F, Weinhardt Batista AP, Moraes Kessler I. Impact of great saphenous vein foam sclerotherapy on quality of life and photoplethysmography findings in chronic venous insufficiency: one-year follow-up. Dermatol Surg 2020; 46 (03) 369-375
    CrossrefPubMedGoogle Scholar
  • 15 Cairns BE, Gazerani P. Sex-related differences in pain. Maturitas 2009; 63 (04) 292-296
    CrossrefPubMedGoogle Scholar
  • 16 Bartley EJ, Fillingim RB. Sex differences in pain: a brief review of clinical and experimental findings. Br J Anaesth 2013; 111 (01) 52-58
    CrossrefPubMedGoogle Scholar
  • 17 Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley III JL. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009; 10 (05) 447-485
    CrossrefPubMedGoogle Scholar
  • 18 Gagliese L, Melzack R. Age-related differences in the qualities but not the intensity of chronic pain. Pain 2003; 104 (03) 597-608
    CrossrefPubMedGoogle Scholar
  • 19 Herr KA, Spratt K, Mobily PR, Richardson G. Pain intensity assessment in older adults: use of experimental pain to compare psychometric properties and usability of selected pain scales with younger adults. Clin J Pain 2004; 20 (04) 207-219
    CrossrefPubMedGoogle Scholar
  • 20 El Tumi H, Johnson MI, Dantas PBF, Maynard MJ, Tashani OA. Age-related changes in pain sensitivity in healthy humans: a systematic review with meta-analysis. Eur J Pain 2017; 21 (06) 955-964
    CrossrefPubMedGoogle Scholar
  • 21 Lautenbacher S, Peters JH, Heesen M, Scheel J, Kunz M. Age changes in pain perception: a systematic-review and meta-analysis of age effects on pain and tolerance thresholds. Neurosci Biobehav Rev 2017; 75: 104-113
    CrossrefPubMedGoogle Scholar
  • 22 Biemans AAM, Kockaert M, Akkersdijk GP. et al. Comparing endovenous laser ablation, foam sclerotherapy, and conventional surgery for great saphenous varicose veins. J Vasc Surg 2013; 58 (03) 727-34.e1
    CrossrefPubMedGoogle Scholar
  • 23 Williamsson C, Danielsson P, Smith L. Catheter-directed foam sclerotherapy for insufficiency of the great saphenous vein: occlusion rates and patient satisfaction after one year. Phlebology 2013; 28 (02) 80-85
    CrossrefPubMedGoogle Scholar
  • 24 Radak DJ, Tanaskovic SZ, Vlajinac HD, Marinkovic JM, Maksimovic MZ. Relationship between pain and CEAP C categories of chronic venous disease. Angiology 2016; 67 (07) 670-675
    CrossrefPubMedGoogle Scholar
  • 25 Bradbury A, Evans C, Allan P, Lee A, Ruckley CV, Fowkes FGR. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 1999; 318 (7180): 353-356
    CrossrefPubMedGoogle Scholar
  • 26 Bradbury A, Evans CJ, Allan P, Lee AJ, Ruckley CV, Fowkes FGR. The relationship between lower limb symptoms and superficial and deep venous reflux on duplex ultrasonography: the Edinburgh Vein Study. J Vasc Surg 2000; 32 (05) 921-931
    CrossrefPubMedGoogle Scholar
  • 27 Howlader MH, Smith PD. Symptoms of chronic venous disease and association with systemic inflammatory markers. J Vasc Surg 2003; 38 (05) 950-954
    CrossrefPubMedGoogle Scholar